Cerebrospinal fluid PKR level predicts cognitive decline in Alzheimer's disease.
The cerebrospinal fluid (CSF) levels of the proapoptotic kinase R (PKR) and its phosphorylated PKR (pPKR) are increased in Alzheimer's disease (AD), but whether CSF PKR concentrations are associated with cognitive decline in AD patients remain unknown. In this study, 41 consecutive patients wit...
Main Authors: | Julien Dumurgier, Francois Mouton-Liger, Pauline Lapalus, Magali Prevot, Jean-Louis Laplanche, Jacques Hugon, Claire Paquet, Groupe d’Investigation du Liquide Cephalorachidien (GIL) Study Network |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3539966?pdf=render |
Similar Items
-
PKR involvement in Alzheimer’s disease
by: Jacques Hugon, et al.
Published: (2017-10-01) -
Blood-Based Kinase Assessments in Alzheimer’s Disease
by: Jacques Hugon, et al.
Published: (2018-11-01) -
Pro-apoptotic kinases levels in cerebrospinal fluid as potential future biomarkers in Alzheimer’s Disease
by: Claire ePAQUET, et al.
Published: (2015-08-01) -
PKR modulates abnormal brain signaling in experimental obesity.
by: Mariko Taga, et al.
Published: (2018-01-01) -
The PKR/P38/RIPK1 Signaling Pathway as a Therapeutic Target in Alzheimer’s Disease
by: Jacques Hugon, et al.
Published: (2021-03-01)